# Vir Biotechnology, Inc.: Form 8-K, filed Feb 22, 2024

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2024-02-22
- Accepted by EDGAR: Feb 22, 2024, 16:12 ET
- Period: 2024-02-21
- Accession: 0001628280-24-006346
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828024006346/vir-20240221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828024006346/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828024006346/vir-20240221.htm

Filed Feb 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-006346. Last ingested by Listed: Oct 28, 2026, 08:38 ET. No prices; not investment advice.